30 Years of Evidence
Join the experts’ corner
Featured Content
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy via Helical TomoTherapy versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable
Stage III NSCLC
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
PO-1392: SBRT monotherapy for low and intermediate risk Prostate Cancer. First Chilean experience
María Fernanda Sánchez, Felipe Maza, Federico Bakal, Piero Bettoli | ESTRO | 2022
PO-1372: Robotic stereotactic body radiotherapy for prostate cancer : an initial monoistitutional experience
Ariadna Sanchez Galvan, Andrei Fodor, Claudio Fiorino, Paola Mangilli, Chiara Lucrezia Deantoni, Cesare Cozzarini, Roberta Tummineri, Simone Baroni, Stefano Lorenzo Villa, Giuseppina Mandurino, Pietro Pacifico,
PO-1370: Metastasis-Directed Therapy with Cyberknife for Oligometastatic Prostate Cancer
Sebastian Exner, Fabian Fehlauer, Saul Esteve Grau | ESTRO | 2022
PO-1292: Stereotactic radiotherapy after chemotherapy in patients with locally advanced pancreatic cancer
Charlotte LE ROY, Rémy Barbe, Roger Sun, Pascal Burtin, Maximiliano Gelli, Eric Deutsch, Jérôme Durand-Labrunie | ESTRO | 2022
PO-1246: Lung SBRT after pneumonectomy
Angela Botticella, Antonin Levy, Olaf Mercier, Guillaume Auzac, Aicha Traore-Diallo, Maxime Frelaut, Pauline Pradere, Caroline Caramella, Ines Kasraoui, Benjamin Besse, David Planchard, Cécile Le Pechoux
PO-1237: Implementation of SAPBI using Cyber-Knife:Dosimetry report and early experiences of a phase II trial
Norbert Mészáros, Viktor Smanykó, Tibor Major, Gábor Stelczer, Levente Jánváry, Zoltán Takácsi-Nagy, Csaba Polgár | ESTRO | 2022
PO-1226: Stereotactic APBI for Early-Stage Breast Cancer: Acute Toxicity Outcomes of a Prospective Trial
Jonathan Cantalino, Brian Collins, Malika Danner, Sonali Rudra, Simeng Suy, Sean Collins, Monica Pernia Marin, Michael Good, Deborah Markiewicz, Rachelle Lanciano, Olusola Obayomi-Davies | ESTRO
PO-1128: Radiosurgery with Cyberknife® for arteriovenous malformations: technical and dosimetrical analysis
Esmeralda Scipilliti, Valentina Borzillo, Rossella Di Franco, Federica Savino, Giuseppe Leone, Mario Muto, Paolo Muto | ESTRO | 2022
PD-0085: SBRT in the management of oligometastatic gynaecological cancer: a mono-institutional experience
Giuseppina Mandurino, Andrei Fodor, Stefano Lorenzo Villa, Flavia Zerbetto, Simone Baroni, Ariadna Sanchez Galvan, Roberta Tummineri, Chiara Lucrezia Deantoni, Paola Mangili, Antonella Del Vecchio, Stefano
OC-0932: Preoperative radiation therapy in early breast cancer: phase II ROCK trial (NCT03520894)
Luca Visani, Icro Meattini, Giulio Francolini, Vanessa Di Cataldo, Carlotta Becherini, Jacopo Nori, Marco Bernini, Lorenzo Orzalesi, Luis Sanchez, Erika Scoccimarro, Sara Lucidi, Chiara Bellini,
A Comparison of AAPM’s TG-51 and IAEA’s TRS-483 Protocols for Clinical Reference Dosimetry of the CyberKnife M6
J Duchaine, D Markel, J-L Ley, D Béliveau-Nadeau, H Bouchard | AAPM | 2022
Dosimetric Evaluation of Stereotactic Prostate Reirradiation Using Cyberknife as An Alternative to HDR Brachytherapy for Locally Recurrent Prostate Cancer
X Zhang, S Jang, S Lee, S Keohan, AE Hirsch | AAPM | 2022
Dosimetric Effect of Intra-Fraction Motion in Multiple Brain Metastases SRS/SRT: An Evaluation Based On a Robotic Radiosurgery System
X Chen, L Chen, J Liu, L Wang, C Ma | AAPM | 2022
Evaluation of the New Independent Dose Calculation SciMoCa as Patient-Specific Quality Assurance in the CyberKnife Treatment of Brain Metastases and Lung Cancer
K Sakai, Y Nakajima, Y Suda, S Kito, Y Sato, K Yasui, Y Arai, T Takizawa, M Sato, Y Fujita | AAPM | 2022
A Dosimetric Comparison for Adaptive Cone-Beam CT and MRI Based Radiotherapy for Stereotactic Partial Breast Irradiation
D Parsons, L Chen, H Lee, Y Zhang, B Cai, T Zhuang, B Hrycushko, C Park, Y Gonzalez, X Zhong, J Visak, C Nwachukwu, N
Multisession stereotactic radiosurgery for large vestibular schwannomas
Casentini L, Fornezza U, Perini Z, Perissinotto E, Colombo F | J Neurosurg | 2015
Intracranial meningioma: Experience with stereotactic radiotherapy
Yazici O, Guzle Adas Y, Kekilli E, Calikoglu T, Bedri Altundag M, Riza Ucer A, Ertas G, Durmus Duzgun S, Ozbagi K, Demirkasimoglu A, Demir E, Aslan B, Kaya B | J BUON | 2018
CyberKnife radiosurgery for acoustic neuromas: Tumor control and clinical outcomes
Przybylowski CJ, Baranoski JF, Paisan GM, Chapple KM, Meeusen AJ, Sorensen S, Almefty KK, Porter RW | J Clin Neurosci | 2019
Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancreatic stump and other stump
Zeng XL, Wang HH, Meng MB, Wu ZQ, Song YC, Zhuang HQ, Qian D, Li FT, Zhao LJ, Yuan ZY, Wang P | Onco Targets Ther | 2016
Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer
Zhu X, Li F, Ju X, Cao F, Cao Y, Fang F, Qing S, Shen Y, Jia Z, Zhang H | Cancer Med | 2017
Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience
Jumeau R, Delouya G, Roberge D, Donath D, Béliveau-Nadeau D, Campeau MP | Dig Liver Dis | 2018
Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancreatic Cancer
Ji X, Zhao Y, He C, Han S, Zhu X, Shen Z, Chen C, Chu X | Front Oncol | 2021
Stereotactic body radiotherapy versus hepatic resection for hepatocellular carcinoma (≤ 5 cm): a propensity score analysis
Sun J, Wang Q, Hong ZX, Li WG, He WP, Zhang T, Zhang AM, Fan YZ, Sun YZ, Zheng L, Duan XZ. | Hepatol Int | 2020